Actively Recruiting
Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment
Led by University of Notre Dame · Updated on 2026-01-15
60
Participants Needed
1
Research Sites
57 weeks
Total Duration
On this page
Sponsors
U
University of Notre Dame
Lead Sponsor
N
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study will help determine the feasibility and acceptability of a brief opioid-informed alcohol intervention in patients receiving prescribed buprenorphine for opioid use who are currently drinking alcohol. It will also provide initial information on whether the intervention improves outcomes related to alcohol use. The results of this proof-of-concept study will inform whether a future larger clinical trial is warranted.
CONDITIONS
Official Title
Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants must be taking prescribed buprenorphine for at least 2 weeks
- Participants must be 18 years or older
- Meet DSM-5 criteria for alcohol use disorder (AUD)
- Participants must report alcohol use 1 day/week on average in the past 28 days
- Participants must be able to read simple English
You will not qualify if you...
- Currently receiving formal alcohol use treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The University of Notre Dame
Notre Dame, Indiana, United States, 46556
Actively Recruiting
Research Team
R
Ryan Carpenter, PhD
CONTACT
B
Beth A Arnold, M.S.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here